Literature DB >> 17257499

A simplified PCR-SSP method for HLA-A2 subtype in a population of Wuhan, China.

Bing Liang1, Lijun Zhu, Zhihui Liang, Xiufang Weng, Xiaoling Lu, Cai'e Zhang, Hui Li, Xiongwen Wu.   

Abstract

HLA-A2 is the most frequent HLA-A allele in all ethnic populations, and an important restriction element for peptide presentation to T cells in infectious disease and cancer. However, the HLA-A2 supertype consisting of up to 75 subtypes, mutation studies and analyses using cytotoxic T lymphocytes suggest the functional relevance of subtype-specific differences in HLA-A2 molecules for peptide binding and T-cell recognition. Therefore, it is necessary for T-cell response study to discriminate the HLA-A2 subtypes and to understand the profile of HLA-A2 allelic distribution in a given population. In this study, we developed a simple, robust approach based on the nested polymerase chain reaction using sequence-specific primers (PCR-SSP) to discriminate 17 HLA-A2 subtypes which cover the most HLA-A2 alleles (> 99% allele frequency) reported in Chinese, using 15 combinations of 19 allelic specific primers. In the first round of PCR, 3 combinations of 5 primers were used to determine whether the tested sample was HLA-A2 positive, meanwhile the subtypes of HLA-A*0209 and HLA-A*0215N were determined for the variant position of these two subtypes is in exon 4 instead of exon 2, 3. Samples of HLA-A2 positive were subtyped in the second round of PCR, using PCR products of the first round as templates. This strategy was applied to test the samples of 78 random HLA-A2 positive individuals for their HLA-A2 subtypes. Those samples were screened for HLA-A2 positive by the first round PCR-SSP from 154 healthy blood donors in Wuhan, China. The subtyping results were verified by using flow cytometric analysis (FCM) with HLA-A2 specific monoclonal antibody BB7.2 and DNA sequencing. The typing results of the samples show 50.7% random individuals in the population carry HLA-A2, HLA-A*0201 ranks the first (allele frequency = 15.5%), followed by A*0207 (5.8%), A*0206 (4.7%), A*0203 (2.6%), A*0210 (0.7%), and these 5 alleles account for 99.0% HLA-A2 subtypes of allele frequency. Our study indicates that the developed typing method is simple and reliable for HLA-A2 subtyping in Chinese, and the profile of allelic distribution of HLA-A2 subtypes is revealed in the population of Wuhan, China.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17257499

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  9 in total

1.  Full screening and accurate subtyping of HLA-A*02 alleles through group-specific amplification and mono-allelic sequencing.

Authors:  Shengli Song; Miaomiao Han; Han Zhang; Yuanxia Wang; Hong Jiang
Journal:  Cell Mol Immunol       Date:  2013-08-19       Impact factor: 11.530

2.  Cytolytic activity of the human papillomavirus type 16 E711-20 epitope-specific cytotoxic T lymphocyte is enhanced by heat shock protein 110 in HLA-A*0201 transgenic mice.

Authors:  Zhenzhen Ding; Rongying Ou; Bing Ni; Jun Tang; Yunsheng Xu
Journal:  Clin Vaccine Immunol       Date:  2013-05-08

3.  Relationship between cytomegalovirus (CMV) IgG serology, detectable CMV DNA in peripheral monocytes, and CMV pp65(495-503)-specific CD8+ T cells in older adults.

Authors:  Sean X Leng; Tao Qu; Richard D Semba; Huifen Li; Xu Yao; Tricia Nilles; Xi Yang; Bhavish Manwani; Jeremy D Walston; Luigi Ferrucci; Linda P Fried; Joseph B Margolick; Jay H Bream
Journal:  Age (Dordr)       Date:  2011-01-28

4.  Human leukemia antigen-A*0201-restricted epitopes of human endogenous retrovirus W family envelope (HERV-W env) induce strong cytotoxic T lymphocyte responses.

Authors:  Xiaoning Tu; Shan Li; Lijuan Zhao; Ran Xiao; Xiuling Wang; Fan Zhu
Journal:  Virol Sin       Date:  2017-08-22       Impact factor: 4.327

5.  Chronic CMV infection in older women: longitudinal comparisons of CMV DNA in peripheral monocytes, anti-CMV IgG titers, serum IL-6 levels, and CMV pp65 (NLV)-specific CD8(+) T-cell frequencies with twelve year follow-up.

Authors:  Huifen Li; Peter Weng; Kevin Najarro; Qian-Li Xue; Richard D Semba; Joseph B Margolick; Sean X Leng
Journal:  Exp Gerontol       Date:  2014-01-15       Impact factor: 4.032

6.  A similarity in peptide cross-reactivity between alloantigen- and nominal antigen-induced CD8+ T cell responses in vitro.

Authors:  Qian Yu; Li Zhang; Lichen Ouyang; Yeli Gong; Zhihui Liang; Guanxin Shen; Xiufang Weng; Xiongwen Wu
Journal:  Immunogenetics       Date:  2012-12-12       Impact factor: 2.846

7.  Improved Natural Killer cell activity and retained anti-tumor CD8(+) T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy.

Authors:  E Muraro; E Comaro; R Talamini; E Turchet; G Miolo; S Scalone; L Militello; D Lombardi; S Spazzapan; T Perin; S Massarut; D Crivellari; Riccardo Dolcetti; D Martorelli
Journal:  J Transl Med       Date:  2015-06-27       Impact factor: 5.531

8.  Glioma-associated antigen HEATR1 induces functional cytotoxic T lymphocytes in patients with glioma.

Authors:  Zhe Bao Wu; Chao Qiu; An Li Zhang; Lin Cai; Shao Jian Lin; Yu Yao; Qi Sheng Tang; Ming Xu; Wei Hua; Yi Wei Chu; Ying Mao; Jian Hong Zhu; Jianqing Xu; Liang Fu Zhou
Journal:  J Immunol Res       Date:  2014-07-09       Impact factor: 4.818

9.  EpicCapo: epitope prediction using combined information of amino acid pairwise contact potentials and HLA-peptide contact site information.

Authors:  Thammakorn Saethang; Osamu Hirose; Ingorn Kimkong; Vu Anh Tran; Xuan Tho Dang; Lan Anh T Nguyen; Tu Kien T Le; Mamoru Kubo; Yoichi Yamada; Kenji Satou
Journal:  BMC Bioinformatics       Date:  2012-11-24       Impact factor: 3.169

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.